Dr. Khadijah Fatimah Shamseddine, MD

Dr. Shamseddine practices at Neurology Specialists, PA. in Fort Myers, Florida.

Dr. Shamseddine's NPI, 1417247792, was assigned on April 7, 2011. Dr. Shamseddine graduated from Ross University School of Medicine in 2010. Dr. Shamseddine holds Florida license ME118066.

Dr. Shamseddine's primary practice is Neurology Specialists, PA., at 9730 Commerce Center Ct, Fort Myers, FL 33908 in Lee County. The practice phone is (239) 590-9190.

Dr. Shamseddine's primary practice is Neurology Specialists, PA. in Fort Myers, Florida. Dr. Shamseddine is also affiliated with Lee Memorial Hospital. The medical group on file is Neurology Specialists. Dmand AI also links Dr. Shamseddine to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shamseddine practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shamseddine's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Shamseddine is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Shamseddine's licenses on file in 8 states: Florida, South Carolina, Pennsylvania, Virginia, Georgia, Indiana, Alabama and Minnesota.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Shamseddine treats.

CMS data shows 806 Medicare services from Dr. Shamseddine across 9 procedure codes in 2024, for 345 Medicare patients. Medicare paid $84,998 for them. Every service was in an office.

CMS counts 345 Medicare patients who saw Dr. Shamseddine in 2024. The largest group is 75 to 84, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shamseddine's median patient age at 76, with 52% women.

In 2024, Dr. Shamseddine wrote 4,052 Medicare Part D claims for 561 patients. 89% of them were for generic drugs. CMS names the drug for 3,834 of them, across 60 drugs with 11 or more claims each, at $1,190,375 in total drug cost. In 2023, CMS named 4,288 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Shamseddine for performance year 2024, reported individually. Dr. Shamseddine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shamseddine as offering telehealth.

CMS Open Payments shows 830 general payments to Dr. Shamseddine from 60 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Abbvie Inc. paid the most, $7,360.

Dr. Shamseddine graduated from Ross University School of Medicine in 2010.

Dr. Shamseddine is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.